A systematic review of pharmacoeconomic studies for pregabalin.


BACKGROUND With anticonvulsant, anxiolytic, and analgesic properties, pregabalin has been evaluated for neuropathic pain and fibromyalgia (FM). These chronic conditions diminish patients' quality of life and increase healthcare utilization and costs. OBJECTIVE To assess the current understanding of economic outcomes associated with pregabalin in… (More)
DOI: 10.1111/papr.12193